How many clinical trials are tracked of maraviroc?

31 trials are tracked, 1 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

maraviroc

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of maraviroc

31 trials tracked of maraviroc: 13 in phase 3 or 4 and 1 with published results. The most-cited published study has 111 citations.

31Trials tracked

13Phase 3 & 4

0Recruiting

1With published results

Phase distribution

Phase 4 8 Phase 3 5 Phase 2 8 Phase 1 6 Other / NA 4

Phase 4 A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac) Completed · 111 cited
Phase 4 CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery Completed
Phase 4 Maraviroc Efficacy for Hepatitis C Completed
Phase 4 Study To Investigate The Hemodynamic Effects Of Single Dose Vardenafil In Subjects Receiving Maraviroc Completed
Phase 4 A Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects Completed
Phase 4 A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B Completed

Show 25 more trials

Phase 4 Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure Completed
Phase 4 Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal Function Completed
Phase 3 Effects of Intensive cART During Acute/Early HIV Infection Completed
Phase 3 Effect of Maraviroc on Endothelial Function in HIV-Infected Patients Completed
Phase 3 Multicenter, Safety Study Of Maraviroc Completed
Phase 3 Optimizing Treatment for Treatment-Experienced, HIV-Infected People Completed
Phase 3 Expanded Access Program for Maraviroc At Multiple Centers Completed
Phase 2 Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS) Completed
Phase 2 Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1 Completed
Phase 2 An Interaction Study to Assess Drug Levels in Healthy Adult Subjects Completed
Phase 2 Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients Completed
Phase 2 Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen Completed
Phase 2 Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) Completed
Phase 2 A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients Completed
Phase 2 Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women Completed
Phase 1 The Maraviroc Darunavir/Ritonavir Once Daily Pharmacokinetic Study Completed
Phase 1 The Maraviroc Central Nervous System (CNS) Study Completed
Phase 1 Combined PD-1 and CCR5 Inhibition for the Treatment of Refractory Microsatellite Stable mCRC Completed
Phase 1 Maraviroc in Patients With Moderate and Severe COVID-19 Completed
Phase 1 A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc Completed
Phase 1 Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection Completed
N/A Non-Interventional Study Of Celsentri® In Treatment Experienced Patients With CCR5-Tropic HIV-Infection Completed
N/A Standard Antiretroviral v. Multi-class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01) Completed
N/A Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy Completed
N/A Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression Completed

Showing the 31 most-cited and recently-updated of 31 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.